Use of apoE genotyping as a pharmacogenetic biomarker in...

Alzheimer's & Dementia 2010 / 7 Vol. 6; Iss. 4

Use of apoE genotyping as a pharmacogenetic biomarker in phase II disease modification trials for Alzheimer's disease

Stone, David J., Molony, Cliona, Potter, William Z.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2010.05.1765
Date:
July, 2010
File:
PDF, 44 KB
english, 2010
Conversion to is in progress
Conversion to is failed